Junji Saruwatari

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Respiratory Syndrome Coronavirus

Clinical Practice

Autism Spectrum Disorder

Top Venues

Nature communications

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Teruhisa Miike, Kentaro Oniki, Makiko Toyoura, Shiro Tonooka, Seiki Tajima, Jun Kinoshita, Junji Saruwatari, Yukuo Konishi
Disruption of Circadian Sleep/Wake Rhythms in Infants May Herald Future Development of Autism Spectrum Disorder. Clocks & sleep 6 (1) (2024)
Teruhisa Miike, Kentaro Oniki, Makiko Toyoura, Shiro Tonooka, Seiki Tajima, Jun Kinoshita, Junji Saruwatari, Yukuo Konishi
Disruption of Circadian Sleep/Wake Rhythms in Infants May Herald Future Development of Autism Spectrum Disorder. Clocks & sleep 6 (1) (2024)
Junji Saruwatari, Tetsuya Kaneko, Tsukasa Murata, Haruka Narise, Sawa Kugimoto, Eri Nishimura, Natsuki Tetsuka, Misaki Ando, Momo Oi, Masako Ota, Nayumi Hamada, Keiichiro Kaneda, Shiro Furusho, Masakatsu Sakamoto, Ayami Kajiwara-Morita, Kazutaka Oda, Kentaro Oniki, Keishi Ueda, Hirofumi Jono, Yasui-Furukori Norio
Effect of concomitant use of yokukansan on steady-state blood concentrations of donepezil and risperidone in real-world clinical practice. Neuropsychopharmacology reports (2024)
Teruhisa Miike, Kentaro Oniki, Makiko Toyoura, Shiro Tonooka, Seiki Tajima, Jun Kinoshita, Junji Saruwatari, Yukuo Konishi
Disruption of Circadian Sleep/Wake Rhythms in Infants May Herald Future Development of Autism Spectrum Disorder. Clocks & sleep 6 (1) (2024)
Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai, Hiromi Aoki-Ogata, Takahiro Ishii, Takuya Kobayakawa, Kenta Nakano, Nobutoki Takamune, Naoki Kishimoto, Shin-Ichiro Hattori, Debananda Das, Yukari Uemura, Yosuke Shimizu, Manabu Aoki, Kazuya Hasegawa, Satoshi Suzuki, Akie Nishiyama, Junji Saruwatari, Yukiko Shimizu, Yoshikazu Sukenaga, Yuki Takamatsu, Kiyoto Tsuchiya, Kenji Maeda, Kazuhisa Yoshimura, Shun Iida, Seiya Ozono, Tadaki Suzuki, Tadashi Okamura, Shogo Misumi, Yoshihiro Kawaoka, Hirokazu Tamamura, Hiroaki Mitsuya
Identification of SARS-CoV-2 M pro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Nature communications 14 (1) (2023)
Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai, Hiromi Aoki-Ogata, Takahiro Ishii, Takuya Kobayakawa, Kenta Nakano, Nobutoki Takamune, Naoki Kishimoto, Shin-Ichiro Hattori, Debananda Das, Yukari Uemura, Yosuke Shimizu, Manabu Aoki, Kazuya Hasegawa, Satoshi Suzuki, Akie Nishiyama, Junji Saruwatari, Yukiko Shimizu, Yoshikazu Sukenaga, Yuki Takamatsu, Kiyoto Tsuchiya, Kenji Maeda, Kazuhisa Yoshimura, Shun Iida, Seiya Ozono, Tadaki Suzuki, Tadashi Okamura, Shogo Misumi, Yoshihiro Kawaoka, Hirokazu Tamamura, Hiroaki Mitsuya
Identification of SARS-CoV-2 M pro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Nature communications 14 (1) (2023)
Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai, Hiromi Aoki-Ogata, Takahiro Ishii, Takuya Kobayakawa, Kenta Nakano, Nobutoki Takamune, Naoki Kishimoto, Shin-Ichiro Hattori, Debananda Das, Yukari Uemura, Yosuke Shimizu, Manabu Aoki, Kazuya Hasegawa, Satoshi Suzuki, Akie Nishiyama, Junji Saruwatari, Yukiko Shimizu, Yoshikazu Sukenaga, Yuki Takamatsu, Kiyoto Tsuchiya, Kenji Maeda, Kazuhisa Yoshimura, Shun Iida, Seiya Ozono, Tadaki Suzuki, Tadashi Okamura, Shogo Misumi, Yoshihiro Kawaoka, Hirokazu Tamamura, Hiroaki Mitsuya
Identification of SARS-CoV-2 M pro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Nature communications 14 (1) (2023)
Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai, Hiromi Aoki-Ogata, Takahiro Ishii, Takuya Kobayakawa, Kenta Nakano, Nobutoki Takamune, Naoki Kishimoto, Shin-Ichiro Hattori, Debananda Das, Yukari Uemura, Yosuke Shimizu, Manabu Aoki, Kazuya Hasegawa, Satoshi Suzuki, Akie Nishiyama, Junji Saruwatari, Yukiko Shimizu, Yoshikazu Sukenaga, Yuki Takamatsu, Kiyoto Tsuchiya, Kenji Maeda, Kazuhisa Yoshimura, Shun Iida, Seiya Ozono, Tadaki Suzuki, Tadashi Okamura, Shogo Misumi, Yoshihiro Kawaoka, Hirokazu Tamamura, Hiroaki Mitsuya
Identification of SARS-CoV-2 M pro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Nature communications 14 (1) (2023)
Yuka Nagase, Takao Satoh, Keiichi Shigetome, Naoto Tokumaru, Erika Matsumoto, Kazunori D Yamada, Tadashi Imafuku, Hiroshi Watanabe, Toru Maruyama, Yasuhiro Ogata, Minoru Yoshida, Junji Saruwatari, Kentaro Oniki
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease. Nutrients 15 (4) (2023)
Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai, Hiromi Aoki-Ogata, Takahiro Ishii, Takuya Kobayakawa, Kenta Nakano, Nobutoki Takamune, Naoki Kishimoto, Shin-Ichiro Hattori, Debananda Das, Yukari Uemura, Yosuke Shimizu, Manabu Aoki, Kazuya Hasegawa, Satoshi Suzuki, Akie Nishiyama, Junji Saruwatari, Yukiko Shimizu, Yoshikazu Sukenaga, Yuki Takamatsu, Kiyoto Tsuchiya, Kenji Maeda, Kazuhisa Yoshimura, Shun Iida, Seiya Ozono, Tadaki Suzuki, Tadashi Okamura, Shogo Misumi, Yoshihiro Kawaoka, Hirokazu Tamamura, Hiroaki Mitsuya
Identification of SARS-CoV-2 M pro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Nature communications 14 (1) (2023)
Taisei Nagasaki, Hitoshi Maeda, Hiroki Yanagisawa, Kento Nishida, Kazuki Kobayashi, Naoki Wada, Isamu Noguchi, Ryotaro Iwakiri, Kazuaki Taguchi, Hiromi Sakai, Junji Saruwatari, Hiroshi Watanabe, Masaki Otagiri, Toru Maruyama
Carbon Monoxide-Loaded Red Blood Cell Prevents the Onset of Cisplatin-Induced Acute Kidney Injury. Antioxidants (Basel, Switzerland) 12 (9) (2023)
Yuka Nagase, Takao Satoh, Keiichi Shigetome, Naoto Tokumaru, Erika Matsumoto, Kazunori D Yamada, Tadashi Imafuku, Hiroshi Watanabe, Toru Maruyama, Yasuhiro Ogata, Minoru Yoshida, Junji Saruwatari, Kentaro Oniki
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease. Nutrients 15 (4) (2023)
Yuka Nagase, Takao Satoh, Keiichi Shigetome, Naoto Tokumaru, Erika Matsumoto, Kazunori D Yamada, Tadashi Imafuku, Hiroshi Watanabe, Toru Maruyama, Yasuhiro Ogata, Minoru Yoshida, Junji Saruwatari, Kentaro Oniki
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease. Nutrients 15 (4) (2023)
Yuka Nagase, Takao Satoh, Keiichi Shigetome, Naoto Tokumaru, Erika Matsumoto, Kazunori D Yamada, Tadashi Imafuku, Hiroshi Watanabe, Toru Maruyama, Yasuhiro Ogata, Minoru Yoshida, Junji Saruwatari, Kentaro Oniki
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease. Nutrients 15 (4) (2023)
Yunyi Yan, Nozomi Kondo, Kentaro Oniki, Hiroshi Watanabe, Tadashi Imafuku, Yuki Sakamoto, Takuro Shigaki, Akari Maruyama, Hitomi Nakazawa, Tetsuya Kaneko, Ayami Morita, Akira Yoshida, Hitoshi Maeda, Toru Maruyama, Hideaki Jinnouchi, Junji Saruwatari
Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney Disease: A Retrospective Longitudinal Observational Study. Journal of diabetes research 2022 (2022)
Keiji Takata, Kentaro Oniki, Yuki Tateyama, Hiroki Yasuda, Miu Yokota, Sae Yamauchi, Norio Sugawara, Norio Yasui-Furukori, Junji Saruwatari
The associations of the number of medications and the use of anticholinergics with recovery from tubal feeding: a longitudinal hospital-based study. BMC geriatrics 20 (1) (2020)
Yuki Sakamoto, Kentaro Oniki, Naoki Kumagae, Kazunori Morita, Koji Otake, Yasuhiro Ogata, Junji Saruwatari
Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals. Disease markers 2019 (2019)